000 01338 a2200397 4500
005 20250515005046.0
264 0 _c20061113
008 200611s 0 0 eng d
022 _a0172-8172
024 7 _a10.1007/s00296-005-0079-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOzgocmen, Salih
245 0 0 _aAntioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns.
_h[electronic resource]
260 _bRheumatology international
_cMay 2006
300 _a598-603 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntidepressive Agents
_xpharmacology
650 0 4 _aDepression
_xmetabolism
650 0 4 _aFemale
650 0 4 _aFibromyalgia
_xetiology
650 0 4 _aHumans
650 0 4 _aLipid Peroxidation
650 0 4 _aMiddle Aged
650 0 4 _aNitric Oxide
_xphysiology
650 0 4 _aOxidative Stress
650 0 4 _aSuperoxide Dismutase
_xmetabolism
650 0 4 _aXanthine Oxidase
_xmetabolism
700 1 _aOzyurt, Huseyin
700 1 _aSogut, Sadik
700 1 _aAkyol, Omer
700 1 _aArdicoglu, Ozge
700 1 _aYildizhan, Hulya
773 0 _tRheumatology international
_gvol. 26
_gno. 7
_gp. 598-603
856 4 0 _uhttps://doi.org/10.1007/s00296-005-0079-y
_zAvailable from publisher's website
999 _c15907847
_d15907847